VectivBio Holding AG VECT NASDAQ

VectivBio Holding AG (VECT) generated $-56.26M in operating cash flow for fiscal year 2022. After capital expenditures of $74K, free cash flow was $-56.33M.

Free cash flow margin was -206% of revenue. Cash conversion ratio was 0.6x, suggesting some earnings are non-cash.

The company returned $5K in share buybacks to shareholders during the period.

Criteria supported by this page:

• HEALTH (67/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
• MOAT (58/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
• INCOME (10/100) — Cash conversion ratio was 0.6x suggests some earnings are non-cash items

Overall SharesGrow Score: 43/100 with 2/7 criteria passed.